Sun Pharmaceuticals Industries plans to acquire an 85.1% stake in JSC Biosintez for a purchase consideration of $60m.

The acquisition will enable Sun Pharmaceuticals to gain local manufacturing capabilities in Russia and expand its presence in the Russian pharmaceutical market.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

"The acquisition enables Allergan to develop novel treatments for Alzheimer’s disease."

Allergan plans to expand its CNS research and development (R&D) pipeline through its recent acquisition of a clinical-stage biopharmaceutical company named Chase Pharmaceuticals Corporation.

Cowen and Company acted as the financial advisers for the transaction.

The acquisition enables Allergan to develop novel treatments for Alzheimer’s disease.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Pharmaceutical Technology Excellence Awards - Nominations Closed

Nominations are now closed for the Pharmaceutical Technology Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
Awarded the 2025 Pharmaceutical Technology Excellence Award for Business Expansion in Integrated Manufacturing, Upperton Pharma Solutions is rapidly expanding its UK GMP and sterile manufacturing footprint. Find out how Upperton’s integrated CDMO model helps pharma companies move from early development to clinical and niche commercial supply with fewer handovers and faster timelines.

Discover the Impact